|Approvals/Requirements Satisfied by eRADIMAGING Courses|
|~ ASRT approval for ARRT® Category A credit||~ MDCB approval by the Medical Dosimetrist Certification (Selected Courses)|
|~ ARMRIT accepted (All MRI Courses)||~ CAMRT and Sonography Canada recognize the ASRT approval (All Courses)|
|~ ARDMS accepted (All Courses)||~ Florida approval for all courses 1 credit or more|
|~ NMTCB accepted (All Courses)||~ California CE requirements met for all radiography courses|
|~ All Courses eligible of international radiographers' CPD requirements||~ All Courses available for RRAs|
|~ ASRT and MDCB are approved continuing education providers of ARRT® and all courses are accepted by ARRT®|
Evidence for Utilizing Magnetic Resonance Imaging to Detect Breast Cancer in the Axilla and Contralateral Breast
Kevin D. Evans, PhD, RT(R)(M)(BD), RDMS, RVS, FSDMS
*Director/Assistant Professor, Radiologic Sciences and Therapy Division, The Ohio State University, Columbus, Ohio.
Address correspondence to: Kevin D. Evans, PhD, RT(R)(M)(BD), RDMS,RVS, FSDMS, Director/Assistant Professor, Radiologic Sciences and Therapy Division, The Ohio State University, 453 West 10th Avenue, 340 A. Atwell Hall, Columbus, OH 43210. E-mail: Kevin.Evans@osumc.edu.
Cancer of the breast is the leading cancer that affects women in the US population, and has consequently been the subject of widespread research and educational campaigns to improve the rates of early detection and successful treatment. Breast cancer incidence in the United States continues to rise at a steady rate, but aggressive research has improved the ability of clinicians to predict breast tumor behavior based on the size of the tumor. Smaller tumors are less likely to metastasize to the lymph nodes, and it is now recommended that women receive regular screening mammograms and clinical breast examinations to identify tumors at an early stage and improve the probability of successful treatment. Furthermore, the American Cancer Society now endorses complimentary imaging of the breast, including a strong endorsement of magnetic resonance imaging (MRI), to detect lymph node involvement and contralateral disease extension. Those at an increased risk of breast cancer due to genetic predisposition, family history, or medical history may especially benefit from the use of MRI of the breast to detect early disease. Although the widespread utilization of MRI of the breast is challenged by concerns of costs, limited equipment availability, and inherent technical limitations, the consideration of MRI in patients with a greater degree of risk factors may improve early disease detection and successful treatment in these individuals. A literature review of MRI of the breast is provided to offer perspective on breast MRI in clinical practice and its utility in detecting nodal involvement and contralateral disease extension.
Full Course Content available to active members of eRADIMAGING.com
* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.